Latest news and insights on the pharmaceutical industry | Indian Pharma Post

Results For "Pnina-Weitz"

3 News Found

Lonza partners with Israel Biotech Fund to support biologics and small molecules development
Biotech | May 25, 2022

Lonza partners with Israel Biotech Fund to support biologics and small molecules development

The two-year agreement will grant Lonza access to IBF's prominent network and allow IBF to benefit from Lonza's manufacturing expertise and knowledge in its due diligence review of potential targets

Lonza, ALSA Ventures collaborate on providing manufacturing services to biotech firms
Biotech | May 10, 2022

Lonza, ALSA Ventures collaborate on providing manufacturing services to biotech firms

The new framework collaboration will support due diligence into ALSA’s potential investments, which will assist with their investment de-risking

Lonza, Forbion, and BioGeneration to focus on manufacturing of small molecules
News | January 19, 2022

Lonza, Forbion, and BioGeneration to focus on manufacturing of small molecules

The extended collaboration will provide services relating to small molecules for both Forbion and BGV portfolio companies active in the biopharmaceutical space

Latest Stories

Astec LifeSciences posts Q4FY24 consolidated loss at Rs. 97.39 lakhs

Dabur India posts Q4 FY24 consolidated PAT at Rs. 349.53 Cr

Wipro to implement Independent Health’s Medicare prescription payment plan platform

White Papers

Chasing Consistency: Centralizing operations data is the key to optimizing chemicals plants

Implementing a digital transformation in chemical operations to maximize profitability

The complexity of compliance

The Sprint to the Summit: Unlocking Lab Efficiency through Digital Transformation

The guiding role of fluidized and spouted bed technologies in particle building processes

Interviews
Capex commitment likely to be in the range of Rs. 200-300 Cr: Dr. R. Ananthanarayanan, CEO, Sajjan India
Capex commitment likely to be in the range of Rs. 200-300 Cr: Dr. R. Ananthanarayanan, CEO, Sajjan India
Dr. R. Ananthanarayanan CEO, Sajjan India
Our focus is on organic expansion and building our own plants...: Dr. Aman Desai, Promoter and Whole Time Director, Aether Industries
Our focus is on organic expansion and building our own plants...: Dr. Aman Desai, Promoter and Whole Time Director, Aether Industries
Dr. Aman Desai Promoter and Whole Time Director, Aether Industries
We have consistently expanded our business in India: Vinod Paremal, President & MD, Evonik, India Region
We have consistently expanded our business in India: Vinod Paremal, President & MD, Evonik, India Region
Vinod Paremal President & MD, Evonik, India Region

Packaging